Access the full text.
Sign up today, get DeepDyve free for 14 days.
J. Cummings, C. Henchcliffe, S. Schaier, T. Simuni, A. Waxman, P. Kemp (2011)
The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration.Brain : a journal of neurology, 134 Pt 11
S. Retchin, B. Hillner (1994)
The Costs and Benefits of a Screening Program to Detect Dementia in Older DriversMedical Decision Making, 14
Computerized Medical Imaging and Graphics Anatomically guided voxel-based partial volume effect correction in brain PET: Impact of MRI segmentation
V. Lehman, R. Carter, D. Claassen, R. Murphy, V. Lowe, R. Petersen, P. Peller (2012)
Visual Assessment Versus Quantitative Three-Dimensional Stereotactic Surface Projection Fluorodeoxyglucose Positron Emission Tomography for Detection of Mild Cognitive Impairment and Alzheimer DiseaseClinical Nuclear Medicine, 37
J. Crary, J. Trojanowski, J. Schneider, J. Abisambra, E. Abner, I. Alafuzoff, S. Arnold, J. Attems, T. Beach, E. Bigio, N. Cairns, D. Dickson, M. Gearing, L. Grinberg, P. Hof, B. Hyman, K. Jellinger, G. Jicha, G. Kovacs, D. Knopman, J. Kofler, W. Kukull, I. Mackenzie, E. Masliah, A. Mckee, T. Montine, M. Murray, J. Neltner, I. Santa-María, W. Seeley, A. Serrano‐Pozo, M. Shelanski, T. Stein, M. Takao, D. Thal, J. Toledo, J. Troncoso, J. Vonsattel, C. White, T. Wisniewski, R. Woltjer, M. Yamada, P. Nelson (2014)
Primary age-related tauopathy (PART): a common pathology associated with human agingActa Neuropathologica, 128
E. Korf, L. Wahlund, P. Visser, P. Scheltens (2004)
Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairmentNeurology, 63
C. Marshall, C. Hardy, A. Volkmer, L. Russell, R. Bond, Phillip Fletcher, C. Clark, C. Mummery, J. Schott, M. Rossor, Nick Fox, S. Crutch, J. Rohrer, J. Warren (2018)
Primary progressive aphasia: a clinical approachJournal of Neurology, 265
D. Perry, Jesse Brown, K. Possin, Samir Datta, A. Trujillo, Anneliese Radke, A. Karydas, J. Kornak, Ana Sias, G. Rabinovici, M. Gorno-Tempini, A. Boxer, Mary May, K. Rankin, V. Sturm, Suzee Lee, B. Matthews, A. Kao, K. Vossel, M. Tartaglia, Z. Miller, S. Seo, M. Sidhu, S. Gaus, A. Nana, J. Vargas, Ji-Hye Hwang, R. Ossenkoppele, A. Brown, E. Huang, G. Coppola, H. Rosen, D. Geschwind, J. Trojanowski, L. Grinberg, J. Kramer, B. Miller, W. Seeley (2017)
Clinicopathological correlations in behavioural variant frontotemporal dementiaBrain, 140
F. Pasquier, D. Leys, J. Weerts, F. Mounier-Véhier, F. Barkhof, P. Scheltens (1996)
Inter- and intraobserver reproducibility of cerebral atrophy assessment on MRI scans with hemispheric infarcts.European neurology, 36 5
K. Vossel, A. Beagle, G. Rabinovici, Huidy Shu, Suzee Lee, Georges Naasan, Manu Hegde, S. Cornes, M. Henry, Alexandra Nelson, W. Seeley, M. Geschwind, M. Gorno-Tempini, T. Shih, H. Kirsch, P. Garcia, B. Miller, L. Mucke (2013)
Seizures and epileptiform activity in the early stages of Alzheimer disease.JAMA neurology, 70 9
I. Matsunari, M. Samuraki, Wei-ping Chen, D. Yanase, Nozomi Takeda, K. Ono, M. Yoshita, H. Matsuda, M. Yamada, S. Kinuya (2007)
Comparison of 18F-FDG PET and Optimized Voxel-Based Morphometry for Detection of Alzheimer's Disease: Aging Effect on Diagnostic PerformanceJournal of Nuclear Medicine, 48
D. Ferreira, C. Verhagen, J. Hernández-Cabrera, L. Cavallin, Chunjie Guo, U. Ekman, J.-Sebastian Muehlboeck, A. Simmons, J. Barroso, L. Wahlund, E. Westman (2017)
Distinct subtypes of Alzheimer’s disease based on patterns of brain atrophy: longitudinal trajectories and clinical applicationsScientific Reports, 7
S. Crutch, M. Lehmann, J. Schott, G. Rabinovici, M. Rossor, Nick Fox (2012)
Posterior cortical atrophyThe Lancet Neurology, 11
A. Fotenos, A. Snyder, L. Girton, J. Morris, R. Buckner (2005)
Normative estimates of cross-sectional and longitudinal brain volume decline in aging and ADNeurology, 64
Kevin Chen, E. Gong, Fabiola Macruz, Junshen Xu, Athanasia Boumis, M. Khalighi, K. Poston, Sharon Sha, Michael Greicius, E. Mormino, John Pauly, Shyam Srinivas, G. Zaharchuk (2019)
Ultra-Low-Dose 18F-Florbetaben Amyloid PET Imaging Using Deep Learning with Multi-Contrast MRI Inputs.Radiology, 290 3
Chrzanowska (1973)
391Folia Morphol (Warsz, 32
L. Mosconi, W. Tsui, K. Herholz, A. Pupi, A. Drzezga, G. Lucignani, E. Reiman, V. Holthoff, E. Kalbe, S. Sorbi, J. Diehl-Schmid, R. Perneczky, F. Clerici, Richard Caselli, B. Beuthien-Baumann, A. Kurz, S. Minoshima, M. Leon (2008)
Multicenter Standardized 18F-FDG PET Diagnosis of Mild Cognitive Impairment, Alzheimer's Disease, and Other DementiasJournal of Nuclear Medicine, 49
Richard Brown, N. Bohnen, K. Wong, S. Minoshima, K. Frey (2014)
Brain PET in suspected dementia: patterns of altered FDG metabolism.Radiographics : a review publication of the Radiological Society of North America, Inc, 34 3
N. Kaltoft, L. Marner, V. Larsen, S. Hasselbalch, I. Law, O. Henriksen (2019)
Hybrid FDG PET/MRI vs. FDG PET and CT in patients with suspected dementia – A comparison of diagnostic yield and propagated influence on clinical diagnosis and patient managementPLoS ONE, 14
J. Hoffman, K. Welsh-Bohmer, M. Hanson, B. Crain, C. Hulette, N. Earl, R. Coleman, Maryland Joseph, Kathleen Alzheimer (2000)
FDG PET imaging in patients with pathologically verified dementia.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 41 11
W. Heiss (2018)
The Additional Value of PET in the Assessment of Cerebral Small Vessel DiseaseThe Journal of Nuclear Medicine, 59
V. Keereman, P. Mollet, Yannick Berker, V. Schulz, S. Vandenberghe (2013)
Challenges and current methods for attenuation correction in PET/MRMagnetic Resonance Materials in Physics, Biology and Medicine, 26
S. Lim, A. Katsifis, V. Villemagne, R. Best, Gareth Jones, M. Saling, J. Bradshaw, J. Merory, M. Woodward, M. Hopwood, C. Rowe (2009)
The 18F-FDG PET Cingulate Island Sign and Comparison to 123I-β-CIT SPECT for Diagnosis of Dementia with Lewy BodiesJournal of Nuclear Medicine, 50
W. Bell, Y. An, Y. Kageyama, Collin English, G. Rudow, O. Pletnikova, M. Thambisetty, Richard O'Brien, A. Moghekar, M. Albert, P. Rabins, S. Resnick, J. Troncoso (2018)
Neuropathologic, genetic, and longitudinal cognitive profiles in primary age-related tauopathy (PART) and Alzheimer's diseaseAlzheimer's & Dementia, 15
G. Chételat, B. Desgranges, B. Landeau, F. Mézenge, J Poline, V. Sayette, F. Viader, F. Eustache, J. Baron (2007)
Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer's disease.Brain : a journal of neurology, 131 Pt 1
R. Ossenkoppele, Brendan Cohn-Sheehy, R. Joie, J. Vogel, Christiane Möller, M. Lehmann, B. Berckel, W. Seeley, Y. Pijnenburg, M. Gorno-Tempini, J. Kramer, F. Barkhof, H. Rosen, W. Flier, W. Jagust, B. Miller, P. Scheltens, G. Rabinovici (2015)
Atrophy patterns in early clinical stages across distinct phenotypes of Alzheimer's diseaseHuman Brain Mapping, 36
K. Vossel, K. Ranasinghe, A. Beagle, D. Mizuiri, S. Honma, Anne Dowling, Sonja Darwish, V. Berlo, D. Barnes, M. Mantle, A. Karydas, G. Coppola, E. Roberson, B. Miller, P. Garcia, H. Kirsch, L. Mucke, S. Nagarajan (2016)
Incidence and impact of subclinical epileptiform activity in Alzheimer's diseaseAnnals of Neurology, 80
P. Nelson, D. Dickson, J. Trojanowski, C. Jack, P. Boyle, K. Arfanakis, K. Arfanakis, R. Rademakers, I. Alafuzoff, J. Attems, C. Brayne, I. Coyle-Gilchrist, H. Chui, D. Fardo, M. Flanagan, G. Halliday, Suvi Hokkanen, S. Hunter, G. Jicha, Y. Katsumata, C. Kawas, C. Keene, G. Kovacs, W. Kukull, A. Levey, Nazanin Makkinejad, T. Montine, S. Murayama, M. Murray, S. Nag, R. Rissman, W. Seeley, R. Sperling, C. White, Lei Yu, J. Schneider (2019)
Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group reportBrain, 142
Nienke Scheltens, Kars Weijden, S. Adriaanse, D. Assema, P. Oomen, W. Krudop, A. Lammertsma, F. Barkhof, T. Koene, C. Teunissen, P. Scheltens, W. Flier, Y. Pijnenburg, M. Yaqub, R. Ossenkoppele, B. Berckel (2018)
Hypometabolism of the posterior cingulate cortex is not restricted to Alzheimer's diseaseNeuroImage : Clinical, 19
Ishii (2001)
548J Nucl Med, 42
C. Jack, R. Petersen, P. O'Brien, E. Tangalos (1992)
MR‐based hippocampal volumetry in the diagnosis of Alzheimer's diseaseNeurology, 42
Gutierrez (2012)
610Comput Med Imaging Graph, 36
M. Lehmann, Cindee Madison, P. Ghosh, W. Seeley, E. Mormino, M. Greicius, M. Gorno-Tempini, J. Kramer, B. Miller, W. Jagust, G. Rabinovici (2013)
Intrinsic connectivity networks in healthy subjects explain clinical variability in Alzheimer’s diseaseProceedings of the National Academy of Sciences, 110
P. Scheltens, L. Launer, F. Barkhof, H. Weinstein, W. Gool (1995)
Visual assessment of medial temporal lobe atrophy on magnetic resonance imaging: Interobserver reliabilityJournal of Neurology, 242
A. Mitchell (2009)
A meta-analysis of the accuracy of the mini-mental state examination in the detection of dementia and mild cognitive impairment.Journal of psychiatric research, 43 4
J. Warren, J. Rohrer, M. Rossor (2013)
Frontotemporal dementiaThe BMJ, 347
J. Suárez, M. Tartaglia, Paolo Vitali, A. Erbetta, John Neuhaus, V. Laluz, Bruce Miller (2009)
CHARACTERIZING RADIOLOGY REPORTS IN PATIENTS WITH FRONTOTEMPORAL DEMENTIANeurology, 73
Mootaz Eldib, J. Bini, D. Faul, N. Oesingmann, C. Tsoumpas, Z. Fayad (2016)
Attenuation Correction for Magnetic Resonance Coils in Combined PET/MR Imaging: A Review.PET clinics, 11 2
M. Raichle, A. Macleod, A. Snyder, W. Powers, D. Gusnard, G. Shulman (2001)
INAUGURAL ARTICLE by a Recently Elected Academy Member:A default mode of brain functionProceedings of the National Academy of Sciences of the United States of America, 98
G. Chrzanowska, A. Beben (1973)
Weight of the brain and body height in man between the ages of 20 and 89 years.Folia morphologica, 32 4
G. Rabinovici, C. Gatsonis, Charles Apgar, K. Chaudhary, I. Gareen, Lucy Hanna, James Hendrix, B. Hillner, Cynthia Olson, O. Lesman-Segev, Justin Romanoff, B. Siegel, R. Whitmer, M. Carrillo (2019)
Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or DementiaJAMA, 321
C. Suemoto, R. Ferretti-Rebustini, R. Rodriguez, R. Leite, Luciana Soterio, S. Brucki, R. Spera, T. Cippiciani, J. Farfel, A. Filho, M. Naslavsky, M. Zatz, C. Pasqualucci, W. Jacob-Filho, R. Nitrini, L. Grinberg (2017)
Neuropathological diagnoses and clinical correlates in older adults in Brazil: A cross-sectional studyPLoS Medicine, 14
L. Hebert, J. Weuve, P. Scherr, Denis Evans (2013)
Alzheimer disease in the United States (2010–2050) estimated using the 2010 censusNeurology, 80
M. Lehmann, E. Koedam, J. Barnes, J. Bartlett, F. Barkhof, M. Wattjes, J. Schott, P. Scheltens, Nick Fox (2013)
Visual ratings of atrophy in MCI: prediction of conversion and relationship with CSF biomarkersNeurobiology of Aging, 34
M. Alcauskas, S. Galetta (2018)
Editors' note: Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB ConsortiumNeurology, 90
Minoshima (1995)
1238J Nucl Med, 36
A. Horváth, A. Szűcs, Z. Hidasi, G. Csukly, G. Barcs, A. Kamondi (2018)
Prevalence, Semiology, and Risk Factors of Epilepsy in Alzheimer's Disease: An Ambulatory EEG Study.Journal of Alzheimer's disease : JAD, 63 3
R. Ossenkoppele, Willemijn Jansen, G. Rabinovici, D. Knol, W. Flier, B. Berckel, P. Scheltens, P. Visser, S. Verfaillie, M. Zwan, S. Adriaanse, A. Lammertsma, F. Barkhof, W. Jagust, B. Miller, H. Rosen, S. Landau, V. Villemagne, C. Rowe, D. Lee, D. Na, S. Seo, M. Sarazin, C. Roe, O. Sabri, H. Barthel, N. Koglin, J. Hodges, C. Leyton, R. Vandenberghe, K. Laere, A. Drzezga, S. Forster, T. Grimmer, P. Sánchez-Juan, J. Carril, V. Mok, V. Camus, W. Klunk, A. Cohen, P. Meyer, S. Hellwig, A. Newberg, K. Frederiksen, A. Fleisher, M. Mintun, D. Wolk, A. Nordberg, J. Rinne, G. Chételat, A. Lleó, R. Blesa, J. Fortea, K. Madsen, K. Rodrigue, D. Brooks (2015)
Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis.JAMA, 313 19
R. Desikan, M. Rafii, James Brewer, Christopher Hess (2013)
An Expanded Role for Neuroimaging in the Evaluation of Memory ImpairmentAmerican Journal of Neuroradiology, 34
F. Wippold, Douglas Brown, D. Broderick, J. Burns, A. Corey, Tejaswini Deshmukh, A. Douglas, K. Holloway, B. Jagadeesan, Jennifer Jurgens, T. Kennedy, Nandini Patel, J. Perlmutter, J. Rosenow, Konstantin Slavin, R. Subramaniam (2015)
ACR Appropriateness Criteria Dementia and Movement Disorders.Journal of the American College of Radiology : JACR, 12 1
M. Wirth, Cindee Madison, G. Rabinovici, Hwamee Oh, S. Landau, W. Jagust (2013)
Alzheimer's Disease Neurodegenerative Biomarkers Are Associated with Decreased Cognitive Function but Not β-Amyloid in Cognitively Normal Older IndividualsThe Journal of Neuroscience, 33
J. Dukart, K. Mueller, Annette Horstmann, H. Barthel, H. Möller, A. Villringer, O. Sabri, M. Schroeter (2011)
Combined Evaluation of FDG-PET and MRI Improves Detection and Differentiation of DementiaPLoS ONE, 6
N. Kerrouche, K. Herholz, R. Mielke, V. Holthoff, J. Baron (2006)
18FDG PET in Vascular Dementia: Differentiation from Alzheimer's Disease Using Voxel-Based Multivariate AnalysisJournal of Cerebral Blood Flow & Metabolism, 26
M. Lehmann, E. Koedam, J. Barnes, J. Bartlett, N. Ryan, Y. Pijnenburg, F. Barkhof, M. Wattjes, P. Scheltens, Nick Fox (2012)
Posterior cerebral atrophy in the absence of medial temporal lobe atrophy in pathologically-confirmed Alzheimer's diseaseNeurobiology of Aging, 33
C. Jack, D. Bennett, K. Blennow, M. Carrillo, B. Dunn, S. Haeberlein, D. Holtzman, W. Jagust, F. Jessen, J. Karlawish, E. Liu, J. Molinuevo, T. Montine, C. Phelps, K. Rankin, C. Rowe, P. Scheltens, E. Siemers, H. Snyder, R. Sperling (2018)
NIA-AA Research Framework: Toward a biological definition of Alzheimer’s diseaseAlzheimer's & dementia : the journal of the Alzheimer's Association, 14
Daniel Paulus, H. Quick (2016)
Hybrid Positron Emission Tomography/Magnetic Resonance Imaging: Challenges, Methods, and State of the Art of Hardware Component Attenuation CorrectionInvestigative Radiology, 51
A. Maass, S. Landau, S. Baker, Andy Horng, S. Lockhart, R. Joie, G. Rabinovici, W. Jagust (2017)
Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's diseaseNeuroImage, 157
I. McKeith, B. Boeve, D. Dickson, G. Halliday, John-Paul Taylor, D. Weintraub, D. Aarsland, J. Galvin, J. Attems, C. Ballard, Ashley Bayston, T. Beach, F. Blanc, N. Bohnen, L. Bonanni, J. Bras, P. Brundin, D. Burn, A. Chen-Plotkin, J. Duda, O. El‐Agnaf, H. Feldman, T. Ferman, D. Ffytche, H. Fujishiro, D. Galasko, J. Goldman, S. Gomperts, N. Graff-Radford, L. Honig, Á. Iranzo, K. Kantarci, D. Kaufer, W. Kukull, V. Lee, J. Leverenz, S. Lewis, C. Lippa, A. Lunde, M. Masellis, E. Masliah, P. McLean, B. Mollenhauer, T. Montine, E. Moreno, E. Mori, Melissa Murray, J. O'Brien, Sotoshi Orimo, R. Postuma, S. Ramaswamy, O. Ross, D. Salmon, A. Singleton, Angela Taylor, Alan Thomas, P. Tiraboschi, J. Toledo, J. Trojanowski, D. Tsuang, Z. Walker, M. Yamada, K. Kosaka (2017)
Diagnosis and management of dementia with Lewy bodiesNeurology, 89
S. Caminiti, Tommaso Ballarini, Arianna Sala, C. Cerami, L. Presotto, R. Santangelo, F. Fallanca, E. Vanoli, L. Gianolli, S. Iannaccone, G. Magnani, D. Perani, Lucilla Scarpini, L. Parnetti, P. Eusebi, G. Frisoni, F. Nobili, A. Picco, E. Scarpini (2018)
FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohortNeuroImage : Clinical, 18
Jennifer Shaffer, J. Petrella, Forrest Sheldon, K. Choudhury, V. Calhoun, R. Coleman, P. Doraiswamy (2013)
Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers.Radiology, 266 2
M. Higuchi, M. Tashiro, H. Arai, N. Okamura, Sachiko Hara, S. Higuchi, Masatoshi Itoh, R. Shin, J. Trojanowski, Hidetada Sasaki (2000)
Glucose Hypometabolism and Neuropathological Correlates in Brains of Dementia with Lewy BodiesExperimental Neurology, 162
C. Jack, R. Petersen, Yuecheng Xu, P. O'Brien, Glenn Smith, R. Ivnik, B. Boeve, E. Tangalos, E. Kokmen (2000)
Rates of hippocampal atrophy correlate with change in clinical status in aging and ADNeurology, 55
F. Fazekas, J. Chawluk, A. Alavi, H. Hurtig, R. Zimmerman (1987)
MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging.AJR. American journal of roentgenology, 149 2
Knopman (2001)
1143Neurology, 56
A. Kelley, K. Mcgarry, Rebecca Gorges, J. Skinner (2015)
The Burden of Health Care Costs for Patients With Dementia in the Last 5 Years of LifeAnnals of Internal Medicine, 163
S. Minoshima, K. Frey, K. Frey, R. Koeppe, N. Foster, David Kuhl (1995)
A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 36 7
J. Ottoy, E. Niemantsverdriet, J. Verhaeghe, E. Roeck, H. Struyfs, Charisse Somers, L. Wyffels, S. Ceyssens, S. Mossevelde, T. Bossche, C. Broeckhoven, A. Ribbens, M. Bjerke, S. Stroobants, S. Engelborghs, S. Staelens (2019)
Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and 18F-FDG-PET imagingNeuroImage : Clinical, 22
Q. Ostrom, H. Gittleman, Peter Liao, Toni Vecchione-Koval, Yingli Wolinsky, C. Kruchko, J. Barnholtz-Sloan (2017)
CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014Neuro-Oncology, 19
Erica Martin-Macintosh, S. Broski, G. Johnson, C. Hunt, Ethany Cullen, P. Peller (2016)
Multimodality Imaging of Neurodegenerative Processes: Part 2, Atypical Dementias.AJR. American journal of roentgenology, 207 4
D. Paternicò, E. Premi, S. Gazzina, M. Cosseddu, A. Alberici, S. Archetti, Maria Cotelli, A. Micheli, M. Turla, R. Gasparotti, A. Padovani, B. Borroni (2016)
White matter hyperintensities characterize monogenic frontotemporal dementia with granulin mutationsNeurobiology of Aging, 38
E. Koedam, M. Lehmann, W. Flier, P. Scheltens, Y. Pijnenburg, Nick Fox, F. Barkhof, M. Wattjes (2011)
Visual assessment of posterior atrophy development of a MRI rating scaleEuropean Radiology, 21
P. Kapeller, R. Barber, R. Vermeulen, H. Adèr, P. Scheltens, W. Freidl, O. Almkvist, M. Moretti, T. Ser, P. Vaghfeldt, C. Enzinger, F. Barkhof, D. Inzitari, T. Erkinjunti, R. Schmidt, F. Fazekas (2003)
Visual Rating of Age-Related White Matter Changes on Magnetic Resonance Imaging: Scale Comparison, Interrater Agreement, and Correlations With Quantitative MeasurementsStroke: Journal of the American Heart Association, 34
V. Berti, L. Mosconi, A. Pupi (2014)
Brain: normal variations and benign findings in fluorodeoxyglucose-PET/computed tomography imaging.PET clinics, 9 2
T. Koesters, K. Friedman, M. Fenchel, Y. Zhan, G. Hermosillo, J. Babb, I. Jelescu, D. Faul, F. Boada, T. Shepherd (2016)
Dixon Sequence with Superimposed Model-Based Bone Compartment Provides Highly Accurate PET/MR Attenuation Correction of the BrainThe Journal of Nuclear Medicine, 57
P. Caroppo, I. Ber, A. Camuzat, F. Clot, L. Naccache, F. Lamari, A. Septenville, A. Bertrand, S. Belliard, D. Hannequin, O. Colliot, A. Brice (2014)
Extensive white matter involvement in patients with frontotemporal lobar degeneration: think progranulin.JAMA neurology, 71 12
M. Hurd, Paco Martorell, K. Langa (2013)
Monetary costs of dementia in the United States.The New England journal of medicine, 369 5
J. Whitwell, G. Höglinger, A. Antonini, Y. Bordelon, A. Boxer, C. Colosimo, T. Eimeren, L. Golbe, J. Kassubek, C. Kurz, I. Litvan, A. Pantelyat, G. Rabinovici, G. Respondek, A. Rominger, J. Rowe, M. Stamelou, K. Josephs (2017)
Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?Movement Disorders, 32
P. Scheltens, Laura Pol (2012)
Atrophy of medial temporal lobes on MRI in “probable” Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlatesJournal of Neurology, Neurosurgery & Psychiatry, 83
Rahul Desikan, Howard Cabral, B. Fischl, B. Fischl, Charles Guttmann, Deborah Blacker, Bradley Hyman, Marilyn Albert, Ronald Killiany (2009)
Temporoparietal MR Imaging Measures of Atrophy in Subjects with Mild Cognitive Impairment That Predict Subsequent Diagnosis of Alzheimer DiseaseAmerican Journal of Neuroradiology, 30
C. Cerami, P. Rosa, G. Magnani, R. Santangelo, A. Marcone, S. Cappa, D. Perani (2014)
Brain metabolic maps in Mild Cognitive Impairment predict heterogeneity of progression to dementiaNeuroImage : Clinical, 7
R. Ossenkoppele, Ruben Smith, T. Ohlsson, O. Strandberg, N. Mattsson, Philip Insel, S. Palmqvist, O. Hansson (2019)
Associations between tau, Aβ, and cortical thickness with cognition in Alzheimer diseaseNeurology, 92
Erica Martin-Macintosh, S. Broski, G. Johnson, C. Hunt, Ethany Cullen, P. Peller (2016)
Multimodality Imaging of Neurodegenerative Processes: Part 1, The Basics and Common Dementias.AJR. American journal of roentgenology, 207 4
(2001)
Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology
W. Shih, Wen-Sheng Huang, P. Milan (2006)
F-18 FDG PET Demonstrates Crossed Cerebellar Diaschisis 20 Years After StrokeClinical Nuclear Medicine, 31
K. Jellinger (2013)
Pathology and pathogenesis of vascular cognitive impairment—a critical updateFrontiers in Aging Neuroscience, 5
N. Salamon, J. Kung, S. Shaw, J. Koo, S. Koh, Joyce Wu, J. Lerner, R. Sankar, W. Shields, J. Engel, I. Fried, H. Miyata, W. Yong, H. Vinters, G. Mathern (2008)
FDG-PET/MRI coregistration improves detection of cortical dysplasia in patients with epilepsyNeurology, 71
N. Jarad (2016)
Clinical reviewChronic Respiratory Disease, 13
Willemijn Jansen, R. Ossenkoppele, D. Knol, B. Tijms, P. Scheltens, F. Verhey, P. Visser, P. Aalten, D. Aarsland, D. Alcolea, M. Alexander, I. Almdahl, S. Arnold, I. Baldeiras, H. Barthel, B. Berckel, K. Bibeau, K. Blennow, D. Brooks, M. Buchem, V. Camus, E. Cavedo, Kewei Chen, G. Chételat, A. Cohen, A. Drzezga, S. Engelborghs, A. Fagan, T. Fladby, A. Fleisher, W. Flier, L. Ford, S. Förster, J. Fortea, N. Foskett, K. Frederiksen, Y. Freund-Levi, G. Frisoni, L. Froelich, T. Gabryelewicz, K. Gill, O. Gkatzima, E. Gómez-Tortosa, M. Gordon, T. Grimmer, H. Hampel, L. Hausner, S. Hellwig, S. Herukka, H. Hildebrandt, L. Ishihara, A. Ivanoiu, W. Jagust, P. Johannsen, R. Kandimalla, E. Kapaki, A. Klimkowicz-Mrowiec, W. Klunk, S. Köhler, N. Koglin, J. Kornhuber, M. Kramberger, K. Laere, S. Landau, D. Lee, M. Leon, Viviana Lisetti, A. Lleó, K. Madsen, W. Maier, J. Marcusson, N. Mattsson, A. Mendonça, O. Meulenbroek, P. Meyer, M. Mintun, V. Mok, J. Molinuevo, H. Møllergård, J. Morris, B. Mroczko, S. Mussele, D. Na, A. Newberg, A. Nordberg, A. Nordlund, G. Novak, G. Paraskevas, L. Parnetti, G. Perera, O. Peters, J. Popp, S. Prabhakar, G. Rabinovici, I. Ramakers, L. Rami, Catarina Oliveira, J. Rinne, K. Rodrigue, E. Rodríguez-Rodríguez, C. Roe, U. Rot, C. Rowe, E. Rüther, O. Sabri, P. Sánchez-Juan, I. Santana, M. Sarazin, J. Schröder, Christin Schütte, S. Seo, F. Soetewey, H. Soininen, L. Spiru, H. Struyfs, C. Teunissen, M. Tsolaki, R. Vandenberghe, M. Verbeek, V. Villemagne, S. Vos, Linda Doorn, G. Waldemar, A. Wallin, Å. Wallin, J. Wiltfang, D. Wolk, M. Zboch, H. Zetterberg (2015)
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.JAMA, 313 19
H. Buchholz, F. Wenzel, M. Gartenschläger, F. Thiele, S. Young, Stefan Reuss, M. Schreckenberger (2015)
Construction and comparative evaluation of different activity detection methods in brain FDG-PETBioMedical Engineering OnLine, 14
Hoffman (2000)
1920J Nucl Med, 41
Jahae Kim, Sang-Geon Cho, Minchul Song, Sae-Ryung Kang, S. Kwon, K. Choi, Seong-Min Choi, Byeong-Chae Kim, Ho-Chun Song (2016)
Usefulness of 3-dimensional stereotactic surface projection FDG PET images for the diagnosis of dementiaMedicine, 95
F. Mettler, M. Guiberteau (1983)
Essentials of Nuclear Medicine Imaging
Scheltens (1992)
967J Neurol Neurosurg Psychiatry, 55
J. Gaugler, B. James, T. Johnson, K. Scholz, J. Weuve (2016)
2016 Alzheimer's disease facts and figuresAlzheimer's & Dementia, 12
S. Minoshima, Norman Foster, Anders Sima, Kirk Frey, R. Albin, David Kuhl (2001)
Alzheimer's disease versus dementia with Lewy bodies: Cerebral metabolic distinction with autopsy confirmationAnnals of Neurology, 50
K. Ishii, Frode Willoch, S. Minoshima, A. Drzezga, E. Ficaro, D. Cross, D. Kuhl, M. Schwaiger (2001)
Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 42 4
M. Mendez (2017)
Early-Onset Alzheimer Disease.Neurologic clinics, 35 2
Catherine Garcia, S. Slone, T. Dolecek, Bin Huang, J. Neltner, J. Villano (2019)
Primary central nervous system tumor treatment and survival in the United States, 2004–2015Journal of Neuro-Oncology, 144
Downloaded from http://journals.lww.com/topicsinmri by BhDMf5ePHKbH4TTImqenVA5KvPVPZ0P5BEgU+IUTEfzO/GUWifn2IfwcEVVH9SSn on 06/04/2020 REVIEW ARTICLE Clinical Use of Integrated Positron Emission Tomography- Magnetic Resonance Imaging for Dementia Patients Timothy M. Shepherd, MD, PhD, and Gopi K. Nayak, MD emergency room and expensive misdirected medical workups, Abstract: Combining magnetic resonance imaging (MRI) with 2-deoxy- explain cognitive and personality changes to the patient and their 2- F-fluoro-D-glucose positron emission tomography (FDG-PET) data loved ones, and identify specific genetic risks to younger family improve the imaging accuracy for detection of Alzheimer disease and related members. Earlier diagnosis can enable patients to participate in dementias. Integrated FDG-PET-MRI is a recent technical innovation that their own financial planning and long-term care decisions, choose allows both imaging modalities to be obtained simultaneously from indi- surrogate decision makers, and participate in medical trials. From vidual patients with cognitive impairment. This report describes the practical a safety standpoint, it has been shown that elderly patients with benefits and challenges of using integrated FDG-PET-MRI to support the dementia who drive have similar risks for car crashes to teenage clinical diagnosis of various dementias. Over the past 7 years, we have drivers. performed integrated FDG-PET-MRI on >1500 patients with possible Reasons for dementia underdiagnosis are
Topics in Magnetic Resonance Imaging – Wolters Kluwer Health
Published: Dec 1, 2019
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.